These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 26898792)

  • 1. [KRAS mutation assay on EUS-FNA specimens from pacients with pancreatic mass].
    Bunganič B; Hálková T; Benešová L; Belšánová B; Laclav M; Hrůzová M; Traboulsi E; Frič P; Suchánek Š; Minárik M; Zavoral M
    Cas Lek Cesk; 2016; 155(1):48-51. PubMed ID: 26898792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Droplet digital polymerase chain reaction detection of KRAS mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation.
    Mansour Y; Boubaddi M; Odion T; Marty M; Belleannée G; Berger A; Subtil C; Laurent C; Dabernat S; Amintas S
    Cancer Cytopathol; 2024 May; 132(5):274-284. PubMed ID: 38308613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliable Detection of Somatic Mutations for Pancreatic Cancer in Endoscopic Ultrasonography-Guided Fine Needle Aspirates with Next-Generation Sequencing: Implications from a Prospective Cohort Study.
    Habib JR; Zhu Y; Yin L; Javed AA; Ding D; Tenior J; Wright M; Ali SZ; Burkhart RA; Burns W; Wolfgang CL; Shin E; Yu J; He J
    J Gastrointest Surg; 2021 Dec; 25(12):3149-3159. PubMed ID: 34244950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control.
    Le Calvez-Kelm F; Foll M; Wozniak MB; Delhomme TM; Durand G; Chopard P; Pertesi M; Fabianova E; Adamcakova Z; Holcatova I; Foretova L; Janout V; Vallee MP; Rinaldi S; Brennan P; McKay JD; Byrnes GB; Scelo G
    Oncotarget; 2016 Nov; 7(48):78827-78840. PubMed ID: 27705932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should
    Béchade D; Palmieri LJ; Bonhomme B; Pernot S; Léna J; Fonck M; Pesqué S; Boillet G; Italiano A; Roseau G
    Therap Adv Gastroenterol; 2024; 17():17562848231224943. PubMed ID: 38250014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic Pancreatitis.
    Cowan RW; Pratt ED; Kang JM; Zhao J; Wilhelm JJ; Abdulla M; Qiao EM; Brennan LP; Ulintz PJ; Bellin MD; Rhim AD
    Clin Transl Gastroenterol; 2021 Nov; 12(11):e00431. PubMed ID: 34797250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
    Allenson K; Castillo J; San Lucas FA; Scelo G; Kim DU; Bernard V; Davis G; Kumar T; Katz M; Overman MJ; Foretova L; Fabianova E; Holcatova I; Janout V; Meric-Bernstam F; Gascoyne P; Wistuba I; Varadhachary G; Brennan P; Hanash S; Li D; Maitra A; Alvarez H
    Ann Oncol; 2017 Apr; 28(4):741-747. PubMed ID: 28104621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cyst fluid harboring a
    Al-Turkmani MR; Gordon SR; Smith KD; Tsongalis GJ; Liu X
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal adenocarcinoma.
    Asano K; Mikata R; Chiba T; Kan M; Maruta S; Yamada T; Miura Y; Shima Y; Sensui M; Nagashima H; Yokoyama M; Ohyama H; Kusakabe Y; Yasui S; Sugiyama H; Ohno I; Kato J; Takano S; Ohtsuka M; Kato N
    Pancreatology; 2021 Apr; ():. PubMed ID: 33865724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA.
    Zvereva M; Roberti G; Durand G; Voegele C; Nguyen MD; Delhomme TM; Chopard P; Fabianova E; Adamcakova Z; Holcatova I; Foretova L; Janout V; Brennan P; Foll M; Byrnes GB; McKay JD; Scelo G; Le Calvez-Kelm F
    EBioMedicine; 2020 May; 55():102462. PubMed ID: 32249202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras gene mutation analysis to diagnosis pancreatic adenocarcinoma from endoscopic ultrasound-guided tissue acquisition; a systematic review and meta-analysis.
    Tamura T; Ashida R; Wan K; Shimokawa T; Kitano M
    Pancreatology; 2024 Feb; 24(1):78-87. PubMed ID: 38042675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor DNA Is an Accurate Diagnostic Tool and Strong Prognostic Marker in Pancreatic Cancer.
    Sellahewa R; Moghaddam SM; Lundy J; Jenkins BJ; Croagh D
    Pancreas; 2023 Mar; 52(3):e188-e195. PubMed ID: 37751379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.
    Cohen JD; Javed AA; Thoburn C; Wong F; Tie J; Gibbs P; Schmidt CM; Yip-Schneider MT; Allen PJ; Schattner M; Brand RE; Singhi AD; Petersen GM; Hong SM; Kim SC; Falconi M; Doglioni C; Weiss MJ; Ahuja N; He J; Makary MA; Maitra A; Hanash SM; Dal Molin M; Wang Y; Li L; Ptak J; Dobbyn L; Schaefer J; Silliman N; Popoli M; Goggins MG; Hruban RH; Wolfgang CL; Klein AP; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Lennon AM
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10202-10207. PubMed ID: 28874546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates.
    de Biase D; de Luca C; Gragnano G; Visani M; Bellevicine C; Malapelle U; Tallini G; Troncone G
    J Clin Pathol; 2016 Apr; ():. PubMed ID: 27122185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretin-induced Duodenal Aspirate of Pancreatic Juice (SIDA): Utility of Commercial Genetic Analysis.
    Simpson RE; Yip-Schneider M; Flick KF; Soufi M; Ceppa EP; Al-Haddad MA; Easler JJ; Sherman S; Dewitt JM; Schmidt CM
    Anticancer Res; 2020 Aug; 40(8):4215-4221. PubMed ID: 32727747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS mutations in pancreatic cancer: could we talk about a risk factor for the development of thromboembolic phenomena?
    Gutiérrez Pérez C; Blanco Abad C; Hontoria Bautista G; Saiz López P; Rodríguez Ledesma I; Espinosa Cabria N; Ramos Reguera I; López Muñoz AM
    Rev Esp Enferm Dig; 2024 Apr; 116(4):236-237. PubMed ID: 37771286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers:
    Ciulla C; Luchini C
    Expert Rev Mol Diagn; 2024 May; 24(5):355-362. PubMed ID: 38708441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in pancreatic cancer.
    Michiels E; Madhloum H; Van Lint S; Messaoudi N; Kunda R; Martens S; Giron P; Olsen C; Lefesvre P; Dusetti N; El Mohajer L; Tomasini R; Hawinkels LJ; Ahsayni F; Nicolle R; Arsenijevic T; Bouchart C; Van Laethem JL; Rooman I
    J Pathol; 2024 Jan; 262(1):76-89. PubMed ID: 37842959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial.
    Chantrill LA; Nagrial AM; Watson C; Johns AL; Martyn-Smith M; Simpson S; Mead S; Jones MD; Samra JS; Gill AJ; Watson N; Chin VT; Humphris JL; Chou A; Brown B; Morey A; Pajic M; Grimmond SM; Chang DK; Thomas D; Sebastian L; Sjoquist K; Yip S; Pavlakis N; Asghari R; Harvey S; Grimison P; Simes J; Biankin AV; ;
    Clin Cancer Res; 2015 May; 21(9):2029-37. PubMed ID: 25896973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of extracellular vesicles with lipid nanoprobe functionalized nanostructured silica.
    Wan Y; Maurer M; He HZ; Xia YQ; Hao SJ; Zhang WL; Yee NS; Zheng SY
    Lab Chip; 2019 Jul; 19(14):2346-2355. PubMed ID: 31232418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.